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Abstract
Fsp27, a member of the Cide family proteins, was shown to localize to lipid droplet and promote lipid storage in adipocytes.
We aimed to understand the biological role of Fsp27 in regulating adipose tissue differentiation, insulin sensitivity and
energy balance. Fsp27
2/2 mice and Fsp27/lep double deficient mice were generated and we examined the adiposity, whole
body metabolism, BAT and WAT morphology, insulin sensitivity, mitochondrial activity, and gene expression changes in
these mouse strains. Furthermore, we isolated mouse embryonic fibroblasts (MEFs) from wildtype and Fsp27
2/2 mice,
followed by their differentiation into adipocytes in vitro. We found that Fsp27 is expressed in both brown adipose tissue
(BAT) and white adipose tissue (WAT) and its levels were significantly elevated in the WAT and liver of leptin-deficient ob/ob
mice. Fsp27
2/2 mice had increased energy expenditure, lower levels of plasma triglycerides and free fatty acids.
Furthermore, Fsp27
2/2 and Fsp27/lep double-deficient mice are resistant to diet-induced obesity and display increased
insulin sensitivity. Moreover, white adipocytes in Fsp27
2/2 mice have reduced triglycerides accumulation and smaller lipid
droplets, while levels of mitochondrial proteins, mitochondrial size and activity are dramatically increased. We further
demonstrated that BAT-specific genes and key metabolic controlling factors such as FoxC2, PPAR and PGC1a were all
markedly upregulated. In contrast, factors inhibiting BAT differentiation such as Rb, p107 and RIP140 were down-regulated
in the WAT of Fsp27
2/2 mice. Remarkably, Fsp27
2/2 MEFs differentiated in vitro show many brown adipocyte characteristics
in the presence of the thyroid hormone triiodothyronine (T3). Our data thus suggest that Fsp27 acts as a novel regulator in
vivo to control WAT identity, mitochondrial activity and insulin sensitivity.
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Introduction
Obesity, representing excess amount of body fat, develops as a
result of a positive energy balance when energy intake exceeds that
of metabolic expenditure. Adipose tissues play crucial roles in the
development of obesity, with white adipose tissue (WAT)
functioning as an energy storage organ,while brown adipose tissue
(BAT) as an energy consumption organ [1]. Morphologically,
white adipocytes are characterized by a large unilocular lipid
droplet that occupies the majority of the cytoplasmic space, while
brown adipocytes contain multiple and relatively smaller lipid
droplets. BAT also contains large numbers of mitochondria
packed with regularly arranged cristae, a characteristic of high
mitochondrial activity. White adipocytes, on the other hand, have
fewer mitochondria and their cristae are more compact. Although
WAT and BAT both express a set of genes that regulates lipolysis,
fatty acid metabolism, triacylglyceride (TAG) storage and insulin
sensitivity [2,3], BAT is known to be functionally more important
as a thermogenic tissue [4]. It expresses a unique protein,
uncoupling protein 1 (Ucp1), which functions to uncouple
oxidative phosphorylation and converting this proton gradient
energy into heat to maintain normal body temperature. Besides
Ucp1, proteins such as type 2 iodothyronine deiondinase (Dio2)
[5] and Cidea [6] have been shown to be highly enriched in BAT.
PGC-1a [7,8], a coactivator of multiple transcription factors such
as nuclear respiratory factors (NRF-1/2) [9,10] and peroxisome
proliferator-activated receptor (PPAR) [11], is also highly
expressed in BAT but low in WAT [12]. Furthermore, PGC-1a
has been shown to coordinate multiple physiological cues for
mitochondrial biogenesis and activity [13].
The exact origin of BAT and WAT and their developmental
relationship is not clear. Both BAT and WAT are generally
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Whereas recent report by Timmoms et al [15] suggest that brown
and white preadipocytes may have different origins. BAT is
apparently more closely related to muscle as brown preadipocytes
appear to express myogenic specific proteins. Interestingly,
differentiated WAT has been shown to acquire certain BAT-like
properties and can be converted into an energy consumption
organ under special conditions. It has been observed that cold-
exposure or administration of b3-agonist could induce the
emergence of multilocular brown adipocytes that contain high
amount of mitochondria and expresses Ucp1 in WAT depots
[16,17]. Furthermore, ablation of b3-adrenoceptor diminishes the
formation of BAT in white fat in cold exposed mice [18],
suggesting the requirement of b-adrenoceptor signaling for the
transdifferentiation of WAT to BAT. A similar increase in the
occurrence of BAT in WAT areas was also observed in different
strains of inbred mice [19]. Mice harboring increased BAT-like
depots show a modest increase in b-adrenoreceptor signaling,
which is sufficient to induce Ucp1 in these BAT-like depots. The
requirement for PPARc in acquiring BAT-like and energy
consuming organ in WAT was also shown in PPARc mutant
(P465L) mice in which its WAT is unable to be converted to BAT
in cold acclimatized mice [20]. On the other hand, attainment of
fatty acid-oxidizing BAT-like cells in the WAT was also observed
in several transgenic and knock-out mouse models. Transgenic
knock-in mouse that replaces the C/EBPa gene with C/EBPb
gene (denoted as C/EBP b/b) was shown to lead to an increase in
the expression of Gsa subunit, cAMP accumulation, enhanced
mitochondrial biogenesis and Ucp1 expression in WAT [21].
WAT in mice with an overexpression of FoxC2 acquired certain
BAT-like properties with increased expression levels of PGC1,
Ucp1 and cAMP pathway proteins such as b3-adrenoceptor and
the protein kinase A alpha regulatory subunit1 [22]. Similarly, in
mice lacking negative regulators for BAT differentiation like p107,
Rb and RIP140, there is a uniform replacement of WAT with BAT
and elevated levels of PGC1a and Ucp1 [23,24]. Although many
factors and regulatory pathways have been shown to play
important roles in maintaining WAT identity, upstream signals
or factors that determine the fate of BAT vs WAT and those that
initiate the conversion of WAT to BAT remain unclear.
Cide proteins including Cidea, Cideb and Fat specific protein
27 (Fsp27, also known as Cidec in human), share homology with
the DNA fragmentation factor DFF40/45 at the N-terminal
region [25]. Our previous work demonstrated that Cidea is
expressed at high levels in BAT[6], whereas Cideb is expressed at
high levels in liver [26]. Mice with deficiency in both Cidea and
Cideb have higher energy expenditure, enhanced insulin sensitivity
and are resistance to high-fat-diet (HFD)-induced obesity and
diabetes [6,26], suggesting a universal role of Cide proteins in the
regulation of energy homeostasis. Fsp27 was originally identified in
differentiated TA1 adipocytes and its expression is regulated by C/
EBP (or C/EBP like) transcription factor [27]. Fsp27 mRNA is
detected at high levels in WAT and moderate levels in BAT [6].
Lower levels of Fsp27 mRNA are present in skeletal muscle (SM)
and lung [28]. In human, it is also detected in heart and many
other tissues [29]. Furthermore, Fsp27 protein is detected in the
lipid droplet enriched fraction [30] and over-expressed Fsp27
protein was shown to be targeted to lipid droplets and promotes
TAG storage [31]. Recently, Fsp27 was also found to be a direct
mediator of PPARc-dependent hepatic steatosis [28]. However, its
physiological role in regulating adipocyte function and the
development of obesity is largely unknown. Here, we observed
that Fsp27 protein was detected in both BAT and WAT, was
dramatically up-regulated in the WAT and liver of ob/ob mice
suggesting that Fsp27 expression is positively correlated with the
development of obesity. Fsp27 deficiency results in dramatically
reduced WAT depot and the acquisition of a brown fat-like
morphology in these WAT, typified by the appearance of smaller
lipid droplets, increased mitochondrial size and their activity.
Furthermore, both Fsp27 deficient and Fsp27/leptin double
deficient mice display improved insulin sensitivity and a lean
phenotype. Genes such as PGC1a, Ucp1 and Dio2 that are
normally expressed in BAT were expressed at high levels in the
WAT of Fsp27
2/2 mice. Furthermore, regulators that maintain
BAT identity like FoxC2 which was known to promote BAT
differentiation was upregulated, whereas factors that inhibit BAT
differentiation such as Rb, p107 and RIP140 were down-regulated
in WAT of Fsp27
2/2 mice. Finally, differentiated mouse
embryonic fibroblasts (MEFs) isolated from Fsp27
2/2 mice
showed an increased propensity to acquire brown adipocyte
characteristics, which is consistent with the in vivo observations in
WAT of the mutant mice.
Results
Fsp27 is highly expressed in adipose tissue and up-
regulated in ob/ob mice
To determine the precise tissue distribution of Fsp27, we
generated polyclonal antibody against Fsp27 and evaluated its
expression profile by western blot analysis. High levels of Fsp27
protein were detected in WAT and moderate levels in BAT. No
Fsp27 protein was detected in other tissues such as liver, kidney,
colon and skeletal muscle (SM) (Fig. 1A). Fsp27 was also detected
in NIH3T3 L1 adipocytes after 4 days differentiation and its levels
remain high during the course of differentiation (Fig. 1B). These
data suggest that Fsp27 is rather exclusively expressed at high
levels in adipose tissue including BAT and WAT. The specific
expression of Fsp27 in adipose tissue prompted us to check
whether levels of Fsp27 protein were correlated with the
development of obesity by examining the levels of Fsp27 in the
WAT of leptin-deficient ob/ob mice. As shown in Fig. 1C, levels of
Fsp27 in WAT were dramatically elevated in ob/ob mice compared
with that of wild type mice. Furthermore, higher levels of Fsp27
were detected in the liver of ob/ob mice that contains large amount
of lipid droplets. Using Fsp27 antibody, we checked the sub-
cellular localization of Fsp27 in differentiated 3T3-L1 cells and
observed that a fraction of Fsp27 was co-localized with lipid
droplet specific marker Perilipin (Fig. 1D), consistent with previous
observation that overexpression of GFP-Fsp27 fusion protein is
targeted to lipid droplet [31,32]. These data suggest that Fsp27
may positively correlate with the development of obesity and the
accumulation of lipid in WAT and hepatocytes.
To elucidate the in vivo function of Fsp27 in adipocyte
differentiation and the development of obesity, we isolated Fsp27
genomic DNA and generated Fsp27-null mice by homologous
recombination. The translation initiation site ATG in exon 2 of
the Fsp27 gene was replaced with a Neo gene cassette that is
transcribed by a PGK promoter from the opposite direction (Fig.
S1A). This strategy effectively deleted the first 31 amino acids of
Fsp27. We confirmed the gene disruption by PCR and western
blot analyses. Genetic deletion generates a PCR product of a 3 Kb
instead of a 5 Kb wild-type band (Fig. 1E). Western blot analysis
also showed that no Fsp27 protein was detected in either WAT or
BAT of Fsp27
2/2mice, suggesting that Fsp27 gene was successfully
disrupted (Fig. 1F).
To investigate the role of Fsp27 in adipocyte differentiation, we
first examined the morphology of fat pads. White fat pads from
various locations such as gonadal fat and subcutaneous fat from
Fsp27 Regulate WAT Identity
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2/2 mice are all significantly reduced in sizes compared with
those from wild type mice. Furthermore, WAT of Fsp27
2/2 mice
isolated from the gonadal region had a dark-red color and
abundant blood vessel circulation (data not shown). Staining by
hemotoxylin and eosin (HE) revealed that white adipocytes from
gonadal region of Fsp27
2/2 mice had small and multiple lipid
droplets, whereas white adipocytes of wild type mice had large and
unilocular lipid droplet (Fig. 1G). Electron microscope (EM)
analysis using semi-thin sections of the WAT showed that white
adipocytes of Fsp27
2/2 mice had defined minuscule lipid droplets
distinguishable from each other, and occupied the cytosol like in
brown adipocytes (Fig. 1G). We also noted that the morphological
features were homogeneous throughout the entire WAT. As Fsp27
is also expressed in BAT, we next compared the morphology of
BAT of wild type and Fsp27
2/2 mice. The BAT dissected from
Fsp27
2/2 mice appear to be pale and slightly enlarged compared
with the wild type BAT. Histological examination of BAT from
wild type and Fsp27
2/2 mice indicates that both contain
multilocular lipid droplets. However, the sizes of lipid droplet in
BAT of Fsp27
2/2 mice were significantly larger than that of
wildtype mice. EM analysis confirmed such an observation
(Fig. 1H). No gross morphological difference for SM, heart or
Figure 1. Fsp27 expression in mice tissue and the morphology of WAT and BAT in Fsp27
2/2 mice. A. Tissue distributions of Fsp27 protein
by western blot analysis. SI, small intestine; BAT, brown adipose tissue; GWAT, gonadal white adipose tissue; SM, skeletal muscle. b-tubulin was used
as a loading control. B. Fsp27 is expressed in differentiated 3T3-L1 adipocytes. FABP (fatty acid binding protein) is used as an adipocyte differentiation
marker. Day 0 represents undifferentiated 3T3-L1 fibroblasts. . C. Elevated Fsp27 protein levels in the WAT and liver of leptin deficient (ob/ob) mice.
WT, wild type. D. Indirect immunofluorescence showing co-localization of Fsp27 with perilipin (Plin) on lipid droplet surface in Day 8 post
differentiated 3T3-L1 cells. E&F . Genotype analyses by PCR (E) and western blot (F) assays using tail genomic DNA and gonadal white adipose tissue
(GWAT) lysate, respectively. +/+, +/2, 2/2 represent wild-type, Fsp27 heterozygous and homozygous mice, respectively. G&H . Morphology of WAT
and BAT of wild type and Fsp27
2/2 mice. HE, hemotoxylin and eosin staining. EM, electron microscope image. 3 months old mice were used for the
experiments. LD, lipid droplets; N, nuclei. Scale bar=25 mm and 1 mm for HE and EM, respectively. .
doi:10.1371/journal.pone.0002890.g001
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not shown). These data suggest that WAT of Fsp27
2/2 mice
acquires a morphology similar to that of BAT with smaller and
multiple lipid droplets and abundant blood vessel circulation.
Lean phenotype in Fsp27
2/2 and leptin/Fsp27 double
deficient mice
The drastic reduction of lipid droplet size in WAT prompted us
to investigate if the atrophy of WAT was due to its loss of lipid
content by measuring the total amount of lipid in gonadal WAT.
We found that total lipid in gonadal white fat (GWAT) pad was
reduced by almost 6 fold (from 0.899560.1436 g in wild type to
0.151260.0079 g in Fsp27
2/2 mice, P,0.001, Fig. 2A), which
strongly suggests that the reduction in fat pad size observed in
WAT of Fsp27
2/2 mice is a result of decreased lipid content in the
adipocytes. The total amount of protein and DNA content within
this fat pad was similar between wild-type and Fsp27 null mice
(data not shown). We then investigated the potential role of Fsp27
in regulating overall body weight and adiposity. Under normal
diet (ND) conditions, the body weight of wild type and Fsp27
2/2
mice were similar (Fig. 2B), while the average body weight of ob/
ob mice was dramatically higher than that of wild type or Fsp27
2/
2 mice. However, the body weight of leptin/Fsp27 double deficient
(ob/ob/Fsp27
2/2) mice was significantly lower than that of ob/ob
mice (Fig. 2B, P,0.001), suggesting that Fsp27-deficiency could
counteract with weight gain in ob/ob mice. When fed with a ND,
the adiposity index of Fsp27
2/2 mice (0.061160.0021) was
approximately 45% lower than that of wild type mice
(0.110160.0008, P,0.0001). We also observed no difference in
overall size with a slightly increased weight of some individual
organs such as liver and heart in Fsp27
2/2 mice compared to
control animals (data not shown). When mice were fed with a
high fat diet (HFD), there was a 54% reduction in adiposity index
in Fsp27 null mice (0.077260.0042) compared to that of wild type
mice (0.169560.0052, P,0.0001, Fig. 2C). While the adiposity
index of ob/ob mice is approximately 30%, the adiposity index for
ob/ob/Fsp27
2/2 mice (10%) was markedly lower (P,0.001),
representing a 70% reduction in total body fat (Fig. 2D).
Consistent with the decreased adiposity index, the weight of fat
pads from different anatomical locations in Fsp27
2/2 as well as
WAT and BAT in ob/ob/Fsp27
2/2 mice was significantly reduced
(Table 1 & 2). Levels of TAG in the WAT of Fsp27
2/2 mice
(25.362.6 mmol/mg protein) were much lower than that of wild
type mice (213.2662.5 mmol/mg protein), representing a 90%
reduction (P,0.01, Fig. 2E). Furthermore, TAG levels in the
WAT of ob/ob/Fsp27
2/2 mice were much lower (27.763.9 vs
586.96100.7 mmol/mg protein, P,0.01, Fig. 2E) compared with
that of ob/ob mice. In addition to a reduced amount of TAG in
WAT, the amount of TAG in the liver and skeletal muscle of
Fsp27
2/2 mice was also significantly reduced (Fig. S1B).
Therefore, the reduced TAG levels in WAT were not due to
alternative lipid storage in other tissues such as liver and SM.
In accordance with the presence of lower amount of WAT,
Fsp27-null mice had significantly lower levels of serum leptin under
either a ND (2.72061.732 pg/ml vs 1.41961.023 pg/ml,
Table 1,P ,0.05) or a HFD feeding condition
(13.15768.824 pg/ml vs 4.5265.588 ng/ml, P,0.001). Levels
of serum leptin under fasting condition were also significantly
reduced in Fsp27
2/2 mice (Fig. 2F, Table 1). Consequently, food
intake, which is regulated by plasma levels of leptin, was 10%
higher in Fsp27-null mice compared to that of wildtype mice
(Fig. 2G, 4.260.036 g/d vs 3.760.026 g/d, P,0.01). We also
measured the levels of plasma TAG and NEFA and found that
when animals were fed with a HFD, levels of plasma TAG were
significantly lower in Fsp27-null mice under fasting conditions
(Table 1,P ,0.001). Levels of plasma non-esterified fatty acids
(NEFA) were also significantly lower in Fsp27-null mice under both
HFD and ND feeding or fasting conditions (Table 1). Surpris-
ingly, we observed lower levels of plasma ketone body under both
ND and HFD fed conditions and under ND fasting condition for
Fsp27
2/2 mice compared with that of wild type mice (Table 1).
Levels of free cholesterol, LDL and HDL were similar between
wild type and Fsp27 null mice (Table 1). Levels of plasma NEFA
and TAG in ob/ob/Fsp27
2/2 mice were also lower than that of ob/
ob mice (Table 2). Levels of plasma glucose under both fed and
fasting conditions were similar between wild type and Fsp27
2/2
mice. However, levels of plasma insulin under ND and fasting
condition were varied and generally higher in Fsp27
2/2 mice than
that of wild type (Table 1). The rate of oxygen consumption
measured by indirect calorimetry was approximately 20% higher
in Fsp27-null mice than in wildtype mice under both ND and
HFD conditions (Fig. 2H), suggesting of an increased whole-body
energy expenditure in Fsp27
2/2 mice. As Fsp27 has been
suggested to play a role in TAG storage and lipolysis [31], we
measured the rate of lipolysis in WAT in the absence or presence
of b-agonist (isoproterenol) and observed that WAT of Fsp27 null
mice had higher rate of basal lipolysis. The rate of b-agonist
induced lipolysis was similar between wild type and Fsp27 null
mice (Fig. 2I, Fig. S1C). We then measured the body
temperature at ambient conditions under both feeding and fasting
conditions and observed that Fsp27
2/2 mice had slightly higher
body temperature compared with that of wild type mice (Fig. S2).
Upon exposure to cold, the core body temperature of wild type
and Fsp27
2/2 mice remain similar at the first 30 min after cold
exposure (Fig. 2J). However, the core body temperature
decreased rapidly in Fsp27
2/2 mice after prolonged cold exposure
(Fig. 2J). Our data therefore clearly suggest that Fsp27-deficiency
in both wild type and leptin deficient mice could lead to a lean
phenotype and less fat accumulation in the WAT.
Improved insulin sensitivity in Fsp27
2/2 and leptin/Fsp27
double deficient mice
The lean phenotype and lower plasma TAG and NEFA in
Fsp27
2/2 and ob/ob/Fsp27
2/2 mice raised the possibility that
their insulin sensitivity might be increased. We then measured the
rates of glucose disposal and insulin sensitivity in Fsp27
2/2 and
ob/ob/Fsp27
2/2 mice by glucose tolerance test (GTT) and insulin
tolerance test (ITT). Fsp27
2/2 mice had significantly lower levels
of blood glucose after administration of an exogenous load of
glucose compared with that of wildtype mice, suggesting an
enhanced glucose disposal (Fig. 3A). Whereas ob/ob mice had
much higher levels of plasma glucose in the GTT test, a typical
phenotype reflecting insulin resistance in these mice. Importantly,
we also observed significantly reduced plasma glucose levels for
ob/ob/Fsp27
2/2 mice (Fig. 3A) compared with that of ob/ob mice.
These data suggest that mice with Fsp27 deficiency in both wild
type and leptin deficient background all have improved glucose
disposal rate. When administered with excessive amounts of
insulin in an ITT test, Fsp27
2/2 mice showed reduced levels of
blood glucose compared with that of wildtype mice (Fig. 3B,
P,0.001). In addition, ob/ob/Fsp27
2/2 mice had significantly
lower levels of blood glucose compared with that of ob/ob mice in
an ITT test (Fig. 3B). Improved glucose disposal and lower blood
glucose levels in ITT experiments suggest that Fsp27
2/2 and ob/
ob/Fsp27
2/2 mice have enhanced insulin sensitivity.
To gain mechanistic insight into the enhanced insulin sensitivity,
we measured levels of IRS1, AKT2 and GLUT4 (principal
mediators of insulin signaling pathway in adipocytes) and assessed
Fsp27 Regulate WAT Identity
PLoS ONE | www.plosone.org 4 August 2008 | Volume 3 | Issue 8 | e2890Figure 2. Lean phenotype of Fsp27 deficient and leptin/Fsp27 double deficient mice. A. Total lipid content of gonadal white fat pad from 3-
month old wild-type (+/+) and Fsp27 mutant (2/2) mice, showing a decrease in lipid content in the WAT of Fsp27
2/2 mice. 5 pairs of mice were used
for analysis. ***p,0.001. B. Body weight of wild type (WT), Fsp27 deficient (Fsp27
2/2), leptin deficient (ob/ob) and leptin/Fsp27 double deficient (ob/
ob/Fsp27
2/2) mice. (wildtype: n=12; Fsp
2/2: n=12, ob/ob, n=10; ob/ob/ Fsp27
2/2, n=11, P,0.001)C. Adiposity index of 10 months old wild-type (+/
+) and Fsp27 mutant mice (2/2) fed with a normal diet (ND) or high fat diet (HFD). Fsp27 mutant mice have significantly less adipose tissue. (ND: +/+
n=13, 2/2 n=14 , HFD: +/+ n=12, 2/2 n=15) (***p,0.001). D. Adiposity index of 3 months old ob/ob and ob/ob/Fsp27
2/2 mice. ob/ob:n=8 ,ob/
ob/Fsp27
2/2: n=8) (***p,0.001). E. TAG content in gonadal white fat (GWAT) of wild type (WT), Fsp27 mutant (Fsp27
2/2), ob/ob, and ob/ob/ Fsp27
2/2
mice fed with normal diet. 3 mice were used for each genotype. **p,0.01. F. Fasting serum leptin level in mice under normal diet (ND) or high-fat
diet (HFD) feeding conditions. ND: +/+ n=11, 2/2 n=8; HFD: +/+ n=14, 2/2 n=11. *p,0.05, ***p,0.001. G. Increased food intake in Fsp27 mutant
and ob/ob/Fsp27
2/2 mice. Wild type: n=15, Fsp27
2/2: n=17; ob/ob:n=6 ,ob/ob/Fsp27
2/2: n=6. **p,0.01. H. Whole body O2 consumption rate of
wild-type or Fsp27 mutant mice fed with a ND or HFD. ND: +/+ n=14, 2/2 n=13, HFD: +/+ n=16, 2/2 n=18. **p,0.01, ***p,0.001. I. Lipolysis rate
in GWAT of 3 months old wild type (+/+) and Fsp27 mutant (2/2) mice. Basal refers to no isoproterenol (Iso,1 mM) treatment.. N=4 for each
genotype. *p,0.05. J. Core Body temperature of wild-type (+/+) or Fsp27 mutant (2/2) mice after animals were exposed to cold ( 4uC). 21 refers to
core body temperature 1 hr before transfer of mice to 4uC. Fsp27 mutant mice had lower core body temperature when exposed to cold. (+/+ n=25,
2/2 n=20, *p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0002890.g002
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2/2 (2/2) mice.
Normal Diet High Fat Diet
+/+ 2/2 +/+ 2/2
N Mean6SEM N Mean6SEM P N Mean6SEM N Mean6SEM P
NEFA (mEq/l) (Fed) 8 1.01460.243 8 0.63560.150 0.0021** 9 1.30560.192 9 1.08660.147 0.0314*
NEFA (mEq/l) (Fast) 8 1.35860.148 8 1.18960.120 0.0250* 9 1.56160.277 9 1.12060.283 0.0012**
TG (mmol/l) (Fed) 8 0.56060.162 8 0.46360.056 0.0525 9 0.61560.136 9 0.24760.032 ,0.0001***
TG (mmol/l) (Fast) 8 1.56360.308 8 1.04560.192 ,0.0001*** 9 2.33560.277 9 1.31460.254 ,0.0001***
Ketone Bodies (mmol/L) (Fed) 14 0.07060.025 12 0.03560.016 0.0003*** 8 0.03660.01 14 0.06660.026 0.0010***
Ketone Bodies (mmol/L) (Fast) 12 1.48760.107 14 0.53460.310 ,0.0001*** 16 0.73060.44 18 0.51560.295 0.1
Insulin (ng/ml) (Fed) 12 0.94660.550 11 1.07660.594 0.591 7 1.52260.657 12 2.06761.07 0.242
Insulin (ng/ml) (Fast) #9 #0.3576#0.084 #7 #0.3776#0.166 0.7586 13 1.76860.464 8 1.76760.836 0.999
Leptin (pg/ml) (Fed) 12 2.72061.732 12 1.41961.023 0.0350* 12 21.15768.824 13 13.5265.588 0.0190*
Leptin (pg/ml) (Fast) 11 1.37560.955 7 0.53160.498 0.0480* 14 13.19864.091 11 3.32961.328 ,0.0001***
Glucose (mmol/l) (Fed) 16 11.7062.635 17 11.75364.479 0.9675 18 11.1063.378 19 10.60561.504 0.5651
Glucose (mmol/l) (Fast) 15 6.88761.132 17 7.72961.768 0.1244 18 10.71761.827 19 11.96861.995 0.0548
Inguinal Fat 15 0.02360.009 14 0.01360.002 0.008** 13 0.03960.011 15 0.01760.004 ,0.0001***
Gonadal Fat 15 0.02460.006 14 0.00460.001 ,0.0001*** 13 0.02860.007 15 0.00660.002 ,0.0001***
Retroperitoneal Fat 15 0.01460.004 14 0.00860.002 0.0001*** 13 0.02360.01 15 0.01760.007 0.07
Mesenteric Fat 15 0.01460.003 14 0.00960.002 ,0.0001*** 13 0.01660.005 15 0.00860.002 ,0.0001***
Subcuteneous Fat 15 0.01860.007 14 0.01260.004 0.009** 13 0.02360.009 15 0.01560.005 0.012*
All values are means6s.e.m. Statistical analysis was done with two-tailed unpaired student t-test. N represents number of mice used.
# Data obtained from 3 months old mice.
*P,0.05,
**P,0.01,
***P,0.001
doi:10.1371/journal.pone.0002890.t001
Table 2. Blood Chemistry and Tissue Weight of ob/ob and ob/ob/Fsp27
2/2 mice
ob/ob ob/ob/Fsp27
2/2
N Mean6SEM N Mean6SEM P
NEFA (mEq/l) (Fed) 8 3.90660.383 8 3.61760.212 0.2946
NEFA (mEq/l) (Fast) 8 4.58260.686 8 3.87360.382 0.01148*
TG (mg/l) (Fed) 8 0.318560.0142 8 0.368260.0216 ,0.0001***
TG (mg/l) (Fast) 8 0.358460.0222 8 0.425660.0232 0.0028**
Cholesterol (mmol/l) (Fed) 8 5.80560.014 8 6.51860.013 0.016*
Cholesterol (mmol/l) (Fast) 8 5.51760.020 8 6.14760.007 0.04748*
Insulin (ng/ml) (Fed) 8 7.98660.162 8 6.29060.209 ,0.0001***
Insulin (ng/ml) (Fast) 8 7.42660.320 8 6.01160.133 ,0.0001***
Glucose (mmol/l) (Fed) 12 17.24 6 1.129 12 16.766 1.210 0.3226
Glucose (mmol/l) (Fast) 12 11.90 6 1.369 12 11.376 0.884 0.2692
Gonadal Fat Pad 10 0.061 6 0.007 10 0.004 6 0.002 ,0.0001***
BAT 10 0.061 6 0.007 10 0.004 6 0.002 ,0.0001***
Liver 10 0.102 6 0.009 10 0.009 6 0.002 ,0.0001***
All values are means 6 s.e.m. Statistical analysis was done with two-tailed unpaired student t-test. N represents number of mice used.
*P,0.05,
**P,0.01,
***P,0.001
doi:10.1371/journal.pone.0002890.t002
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presence of insulin. Levels of IRS1 were slightly increased in the
WAT of Fsp27
2/2 mice (P,0.01, Fig. 3C, Fig. S3A). However,
levels of tyrosine phosphorylation on IRS1 were drastically
increased in the WAT of Fsp27 mutant mice (approximately 8 fold
higher, P,0.001, Fig. 3C, Supplementary 3A). In addition,
levels of IRS1 tyrosine phosphorylation in the WAT of ob/ob/
Fsp27
2/2 mice were also significantly increased compared with that
in ob/ob mice (Fig. 3D,P ,0.001, Fig. S3A). Levels of AKT2 were
also significantly increased in Fsp27
2/2 and ob/ob/Fsp27
2/2 mice
(Fig. 3 E&F,P ,0.01 & P,0.001, Fig. S3B). Furthermore, levels
of phosphorylated-AKT2 in the presence of insulin were signifi-
cantly increased in the WAT of Fsp27
2/2 and ob/ob/Fsp27
2/2
mice. No difference in IRS2 phosphorylation was observed in
Fsp27-null mice (data not shown). Levels of IRS1 and AKT2, and
their phosphorylated products in BAT, liver and skeletal muscle are
similar between wild type and Fsp27
2/2 mice (Fig. S4), suggesting
no change in insulin sensitivity in these tissues. Surprisingly, we
observed significantly increased levels of GLUT4 in the WAT of
Fsp27
2/2 and ob/ob/Fsp27
2/2 mice (Fig. 3 E&F, P,0.001, Fig.
S3C). These data suggest that insulin sensitivity in the WAT of
Fsp27
2/2 and ob/ob/Fsp27
2/2 mice was improved possibly due to
the increased protein levels of IRS1, AKT2 and GLUT4, as well as
IRS1 tyrosine phosphorylation.
Increases in mitochondrial size, activity and proteins in
WAT of Fsp27
2/2 mice
To investigate the underlying mechanism for reduced lipid
accumulation, increased whole body metabolism in WAT and lean
Figure 3. Increased insulin sensitivity in Fsp27
2/ and ob/ob/Fsp27
2/2 mice. GTT (A) and ITT (B) experiments using 10-week-old wild type
(WT), Fsp27 mutant (Fsp27
2/2), leptin deficient (ob/ob) and leptin/Fsp27 double deficient (ob/ob/Fsp27
2/2) mice. 6 mice from each group were used
for the experiment. *p,0.05; **p,0.01; ***p,0.001. Western blot analysis for levels of IRS-1 and insulin stimulated IRS-1 tyrosine phosphorylation (p-
IRS) in the WAT of wild type (WT) and Fsp27 mutant (Fsp27
2/2) mice (C) and in the WAT of leptin deficient (ob/ob) and leptin/Fsp27 double deficient
(ob/ob/Fsp27
2/2) mice (D). . E&F .Western blot analysis of total AKT2, phosphor-AKT2 (pAKT2) and GLUT4 protein levels in WAT of wild type (WT),
Fsp27 mutant (Fsp27
2/2), leptin deficient (ob/ob) and leptin/Fsp27 double deficient (ob/ob/Fsp27
2/2) mice. b-actin was used as loading control.
doi:10.1371/journal.pone.0002890.g003
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morphology of Fsp27
2/2 white adipocytes by EM analysis. The
mitochondria in wildtype white adipocytes were smaller and more
compact. However, the mitochondrial volume appears to be
dramatically increased in gonadal white adipocytes of Fsp27-null
mice compared with that of wild type mice (Fig. 4A). Mitochon-
dria in Fsp27
2/2 white adipocytes were full of straight or slightly
wavy cristae that transverse the width of the mitochondria, a
typical characteristic of metabolically active mitochondria
(Fig. 4A). While brown adipocytes of wild type mice have larger
mitochondria in their cytosol with dense and regular cristea
aligned along the mitochondrial matrix, mitochondria from
Fsp27
2/2 brown adipocytes were irregular in size and had
significantly fewer cristea in its matrix, suggesting their lower
Figure 4. Increased mitochondria activity in the WAT of Fsp27 mutant mice. A. Electron microscope image of mitochondria in gonadal
WAT (GWAT) (Scale Bar=0.2 mm) and BAT (Scale Bar=0.5 um) of wild-type and Fsp27
2/2 mice showing enlarged mitochondria in Fsp27
2/2 mice. N:
nucleus, L: lipid droplet, M: mitochondria. B. Cytochrome oxidase IV (Cox) activity in GWAT, BAT, muscle and liver (n=4). COXIV activity in Fsp27
2/2
mice is higher in GWAT (*p,0.05), but lower in BAT (**p,0.01) as compared with that of wild type mice. No difference in COX activity is detected in
muscle or liver. C. Mitochondrial oxygen consumption rate is higher in WAT of Fsp27
2/2 mice. (*p,0.05) (n=3). D. Western blot analysis of various
mitochondrial proteins in the WAT of wild-type and Fsp27 mutant mice, showing higher level in Fsp27 mutant WAT. (n=4), CytoC, cytochrome C. b-
tubulin was used as loading control. D. Relative mRNA levels of COXIV, CPT1 and CPT2 in the WAT of wild type (+/+) and Fsp27 mutant mice (2/2).
doi:10.1371/journal.pone.0002890.g004
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morphology was observed in muscle cells and hepatocytes of wild
type and Fsp27
2/2 mice (data not shown).
To investigate whether the increased mitochondrial size is
correlated with enhanced activity, we measured the activity of
mitochondrial cytochrome C oxidase (COX), which is the terminal
electron acceptor that transfers electron from cytochrome C to
molecular oxygen. We observed that COX activity in the
mitochondria of Fsp27
2/2 WAT (12.2960.7381 U/min/mg) is
approximately 5 fold higher than that of wild type WAT
(3.39460.9319 U/min/mg, P#0.01, Fig. 4B). In contrast, COX
activity in BAT of Fsp27
2/2 mice (114.769.402 U/min/mg) was
slightly lower than that of wild type mice (15968.622 U/min/mg).
Consistent with their decreased mitochondrial activity, levels of
mitochondrial proteins such as Cpt1, Cpt2 and BAT specific proteins
such as Ucp1 and PGC1 were decreased in the BAT of Fsp27
2/2
mice (Fig. S5). No difference in COX activity was observed in
muscleand liver between wild type and Fsp27
2/2 mice (Fig. 4B).To
further confirm that mitochondrial activity is increased in mutant
WAT, we measured the rate of mitochondrial oxygen consumption
from WAT of wildtype and Fsp27
2/2 mice using a Clark-type
electrode. Mitochondrial oxygen consumption rate of Fsp27
2/2
WAT was 2 fold higher (44.5263.186 mol/mg) than that of wild-
type mice (22.3964.037 mol/ng, P,0.05, Fig. 4C). These data all
indicate that Fsp27
2/2 white adipocytes showed increased mito-
chondrial size and enhanced mitochondrial activity.
To assess the molecular basis of increased mitochondria activity
in Fsp27
2/2 mice, we measured the expression levels of several
genes, including cytochrome c, COXIV, CPT1 and CPT2, that
are involved in mitochondrial oxidative phosphorylation and fatty
acid oxidation. We observed that their protein levels were
markedly increased in Fsp27
2/2 WAT. Hsp60, a chaperon
protein localized in the mitochondrial matrix, was also signifi-
cantly increased (Fig. 4D), consistent with the increased
mitochondrial biogenesis in Fsp27
2/2 white adipocytes. We
further measured their mRNA levels by semi-quantitative PCR
and observed that the mRNA levels of COXIV, CPT1 and CPT2
were significantly increased in Fsp27
2/2 mice, consistent with the
increase in their protein levels (Fig. 4E). These data suggest that
WAT of Fsp27
2/2 mice have increased mitochondrial activity due
to increases mitochondrial size and higher levels of mitochondrial
gene expression.
Up-regulation of crucial transcriptional factors and BAT-
specific proteins in Fsp27
2/2 WAT
The morphological resemblance of WAT to that of BAT, and
the increased mitochondrial activity in WAT of Fsp27
2/2 mice,
suggest that Fsp27
2/2 WAT might have acquired BAT-like
properties. To determine the extent of shifting of the physiology
and gene expression profiles of WAT to BAT in Fsp27
2/2 mice,
we checked the expression levels of BAT-specific genes and several
transcriptional regulators by real-time PCR analysis. We observed
that the mRNA levels of the brown fat specific gene Ucp1 were
significantly elevated in the WAT of Fsp27
2/2 mice compared
with that of wild type mice (approximately 20 folds, P,0.05,
Fig. 5A). The mRNA levels of Cidea and Dio2, a protein that
catalyzes the conversion of T4 (thyroxine) into the active substance
T3 (3, 5, 39-tri-iodothyronine) in BAT, were also significantly
increased in the WAT of Fsp27
2/2 mice. In addition, mRNA
levels of PGC1a, PPARa and PPARc were all increased in the
WAT of Fsp27
2/2 mice. Consistently, mRNA levels for FABP
(aP2), a downstream target of PPARc, were also increased
(Fig. 5A). Importantly, FoxC2, a crucial regulator of cAMP
pathway that promotes BAT differentiation, was increased in the
WAT of Fsp27
2/2 mice. On the other hand, Rb, p107 and
RIP140, factors that were negatively associated with WAT to BAT
transformation were substantially decreased in WAT of Fsp27
2/2
mice (Fig. 5A). Furthermore, mRNA levels for GLUT4 and
AKT2 were significantly increased (Fig. 5A), consistent with
increased insulin sensitivity in Fsp27 null mice. In accordance with
their increased mRNA levels, protein levels for Cidea, PGC1a,
Ucp1 and Fabp were significantly increased in WAT of Fsp27
2/2
mice (Fig. 5B &C). We then checked the protein levels of Cidea,
PGC1a, Ucp1 and FABP in the WAT of ob/ob and ob/ob/Fsp27
2/
2 mice and observed that their levels were all significantly up-
regulated in ob/ob/Fsp27
2/2 mice (Fig. 5B & C). These data
suggest that Fsp27 acts upstream to control insulin signaling
pathway and modulates programs that maintain WAT identity
such as FoxC2, Rb, p107 and RIP140. Furthermore, Fsp27
regulates the expression of PPAR and PGC1 that in turn regulate
their downstream targets such as Ucp1, Dio2 and Cidea
expression.
Differentiated Fsp27
2/2 MEFs display characteristics of
brown adipocyte
To check whether the conversion of WAT to BAT in Fsp27
2/2
mice is cell autonomous or requires exogenous signals, we isolated
mouse embryonic fibroblasts (MEFs) from wild type and Fsp27
2/2
mice and induced them to differentiate into adipocytes in vitro. The
morphologies of differentiated MEFs from wildtype and Fsp27
2/2
mice are very different. Wildtype adipocytes have fewer but larger
lipid droplets while differentiated Fsp27
2/2 MEFs possesses more
but smaller lipid droplets (Fig. 6A). The small lipid droplets in
Fsp27
2/2 adipocytes tend to cluster together, fully resembling the
morphology seen in WAT from Fsp27
2/2 mice. Furthermore,
levels of TAG from differentiated Fsp27
2/2 MEFs were
significantly lower than that of differentiated wild type MEFs
(Fig. 6B). The lower amount of TAG and smaller lipid droplets in
Fsp27
2/2 adipocytes was not due to their defect in differentiation
as the levels of adipocyte-specific markers such as Fabp and
Perilipin-A were in fact slightly higher in Fsp27
2/2 adipocytes
(data not shown). Furthermore, the lower amount of TAG in
differentiated Fsp27
2/2 MEFs was not due to a decrease in FFA
uptake as the rate of fatty acid uptake was similar between
differentiated wildtype and Fsp27
2/2 MEFs (data not shown).
Consistent with data observed with WAT of Fsp27
2/2 mice, rates
of basal lipolysis were all significantly increased in differentiated
Fsp27
2/2 MEFs compared with that of wild type cells (Fig. 6C,
P,0.05). These data suggest that Fsp27 deficiency in differenti-
ated MEFs leads to lower TAG accumulation, increased basal
lipolysis and smaller lipid droplets.
We then checked the expression levels of PGC1a, Ucp1, Cidea
and mitochondrial proteins in differentiated Fsp27
2/2 MEFs in
the presence or absence of T3. In the absence of T3, protein levels
for PGC1a were similar for differentiated wild type and Fsp27
2/2
MEFs (Fig. 6D), which is in drastic contrast to the phenotypic
changes seen between the wildtype and mutant adipocytes derive
from the mice. In addition, protein levels for mitochondrial
proteins for oxidative phosphorylation such as cytochrome-C and
COXIV were also similar in differentiated wild type and Fsp27
2/2
MEFs. Furthermore, no up-regulation of Ucp1 and Cidea was
observed in differentiated Fsp27
2/2 MEFs compared to wild type
(Fig. 6D). These data suggest that in vitro molecular induction of
Ucp1 expression and upregulation of mitochondrial proteins for
oxidative phosphorylation in Fsp27
2/2 adipocytes requires
exogenous signals or factors, and are likely influenced by
endocrine regulation. We then tested several factors known to
promote BAT differentiation such as b-agonist, retinoid acid and
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of T3 in the differentiation medium, basal lipolysis rate (Fig. 6C)
and protein levels for PGC1a were significantly increased in
differentiated Fsp27
2/2 MEFs compared with that of wild type
cells (Fig. 6D, Fig. S6,P ,0.05). Ucp1 protein was also induced
in the presence of T3 in differentiated wild type MEFs but its levels
were increased by approximately two fold in differentiated
Fsp27
2/2 MEFs (P,0.05). Levels of Cidea were also significantly
increased by more than 3 fold in differentiated Fsp27
2/2 MEFs
(Fig. 6D, Fig. S6, P,0.05) in the presence of T3, although no
difference in mRNA levels for Ucp1 or Cidea was observed
between wild type and Fsp27
2/2 MEFs. Furthermore, levels of
mitochondrial proteins such as COXIV, cytochrome C and Hsp60
were also higher. Consistent with the increase in PGC1a protein
levels, the mRNA levels for PGC1a were also significantly
increased (approximately 4 fold) and FoxC2 (2 fold) in differen-
tiated Fsp27
2/2 MEFs in the presence of T3 (Fig. 6E). Consistent
with our in vivo data, levels of Rb and RIP140 mRNAs were
significantly decreased in differentiated Fsp27
2/2 MEFs. The
mRNA levels for GLUT4 were also increased in differentiated
Fsp27
2/2 MEFs. The rate of fatty acid oxidation, an indicator of
mitochondrial activity, is increased in differentiated Fsp27
2/2
adipocytes in the presence of T3 at various time points tested
(Fig. 6F). These data suggest that Fsp27
2/2 MEFs attain certain
characteristics of brown adipocyte-like cells in vitro and that the
thyroid hormone T3 plays a critical role in this phenotypic
changes.
Discussion
Through genetic deletion of Fsp27, we have found that Fsp27
deficiency causes reduced white fat pads, decreased adiposity,
increased whole body metabolism, enhanced insulin sensitivity and
a lean phenotype not only in a wild type background but also in
leptin deficient obese mice. The anti-obesity effect of Fsp27
deficiency in wild type and ob/ob background is likely due to
increased energy expenditure in WAT of Fsp27
2/2 mice as it has
markedly increased mitochondrial activity, which could in turn
Figure 5. Altered expression levels of crucial metabolic regulators and BAT-specific factors in Fsp27 mutant mice. A. Real-time PCR
analysis of regulatory factors and BAT specific gene expression in the WAT of wild type (+/+) and Fsp27
2/2 mice (2/2). Significantly higher levels of
BAT markers expression in Fsp27 mutant mice WAT were detected (*p,0.05; **p,0.01). B. Western blot analysis showing increased protein levels of
Cidea, PGC1a, Ucp1 and FABP in the WAT of wildtype, ob/ob, Fsp27
2/2 and ob/ob/Fsp27
2/2of Fsp27 mutant mice. b-tubulin was used as loading
control. C. Densitometric reading of relative levels of the indicated proteins in western blot analysis (as in B) were quantitated in these mouse strains.
Similar experiments were done five times and the intensity of individual band in each western blot was quantified by TOTAL-LAB software (Nonlinear
Dynamics, UK) and used for statistical analysis. The relative protein level in wildtype and ob/ob mice was designated as 1.0. **p,0.01.
doi:10.1371/journal.pone.0002890.g005
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enhanced overall whole body energy expenditure. Furthermore,
we could rule out the contribution of other tissues such as muscle
and liver to the decreased overall adiposity as we observed no
difference in morphology and mitochondrial activity in these
tissues between wild type and Fsp27
2/2 mice.
Besides its role in regulating adiposity, Fsp27 also plays an
important role in modulating insulin sensitivity. Both Fsp27
2/2
and ob/ob/Fsp27
2/2 mice have increased glucose uptake and
improved insulin sensitivity. The mechanism by which Fsp27
2/2
mice had increased insulin sensitivity is likely due to an increased
expression of GLUT4 and AKT2 and increased tyrosine
Figure 6. Differentiated Fsp27
2/2 MEFs display many brown adipocyte characteristics. A. Smaller lipid droplets in differentiated Fsp27
mutant mouse embryonic fibroblasts (MEFs). Lipid droplets were stained with BODIPY493/503, and nuclei were stained with Hochest 366243. Fields
shown were visualized under fluorescence microscope at appropriate wavelengths for GFP (green) and Hoechst (blue). B. Lower TAG accumulation in
differentiated Fsp27
2/2 MEFs (2/2) than in wildtype (+/+) cells. (n=4) (**p,0.01; ***p,0.001). C. Increased basal lipolysis rate in differentiated
Fsp27
2/2 MEFs in the absence or presence of T3 (10 nM) in the differentiation medium. (n=3) (*p,0.05; **p,0.01). D. Western blot analysis showing
levels of various proteins in differentiated MEF cells in the absence or presence of T3 (10 nM). b-tubulin was used as a loading control. E. Relative
mRNA levels of various genes in differentiated wildtype (+/+) and Fsp27
2/2(2/2)MEFs. mRNA levels for Rb were measured using MEFs that were
differentiated for 3 days. (n=4) (*p,0.05). F. Higher levels of fatty acid b-oxidation rate in differentiated Fsp27
2/2 (2/2) MEFs as compared to
wildtype (+/+) MEFs in the presence of T3 (10nM). (n=4) (**p,0.01). Results of relative amount of
3H2O released into the medium after four (4h) or six
(6h) hours chase of pre-labelled MEFs with cold palmitate. Wildtype oxidation rate at 4h is set to 100. G. Regulatory and metabolic pathways that are
altered in the WAT of Fsp27
2/2 mutant mice, leading to anti-obesity and insulin sensitive phenotype.
doi:10.1371/journal.pone.0002890.g006
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difference in glucose levels after glucose and insulin administration
under normal diet condition (Fig. 3A & B), which is in contrast to
the drastic difference in the phosphorylation of IRS1 and AKT2
(Fig. 3C to 3F) in the WAT of Fsp27
2/ mice. Glucose uptake and
insulin sensitivity are contributed by multiple organs such as
adipose tissue, liver and muscle, depending on the status of energy
homeostasis within the body. As we observed no difference in the
levels of AKT phosphorylation in the skeletal muscle, liver or
BAT, it is possible that under normal diet feeding condition when
animals are insulin sensitive, the impact of increased insulin
sensitivity in WAT on whole body glucose level control would be
marginal. However, under the condition that animals are already
insulin resistant (such as in the ob/ob background), increased
insulin sensitivity in WAT of Fsp27 deficiency in leptin and Fsp27
double deficient mice caused drastically reduced glucose levels
after glucose and insulin administration.
We observed that unlike wild type white adipocytes that contain
a large unilocular lipid droplet, Fsp27
2/2 white adipocytes have
small but numerous lipid droplets in their cytosol, with nuclei
localize at the center of the cell. Furthermore, Fsp27
2/2 white
adipocytes contain significantly larger mitochondria, dramatically
higher mitochondrial activity and markedly elevated levels of
many mitochondrial proteins for fatty acid oxidation, electron
transport chain and TCA cycles. BAT enriched proteins such as
Ucp1, Cidea and Dio2 were all significantly up-regulated in
Fsp27
2/2 white adipocytes. Expression of PPAR family proteins
(PPARa and c) and PGC1a, crucial factors for controlling
adipocytes differentiation, lipolysis, fatty acid transport and
oxidation, glycolysis and uncoupling are also upregulated in
WAT of Fsp27
2/2 mice. Furthermore, the increase in Dio2
expression could also boost the local concentration of T3, and
serve as a source for systemic T3 in WAT of Fsp27
2/2 mice,
resulting in the increased PGC1a and Ucp1 expression. These
alterations all point to a possibility that the WAT tissue of Fsp27
2/
2 mice has acquired certain BAT-like properties, and hence was
transformed from a typical energy storage tissue into an energy
consuming tissue. Although the exact mechanism by which
Fsp27
2/2 WAT is transformed into a BAT-like tissue is not clear,
we observed enhanced expression of genes regulating cAMP
signaling pathway such as FoxC2 in WAT of Fsp27
2/2 mice.
Enhanced FoxC2 expression could contribute to the increased
expression of PGC1a and Ucp1. We also observed dramatically
reduced expression of Rb and its homolog p107 that were known
to negatively regulate PGC1a expression and BAT differentiation.
Furthermore, we observed reduced expression of a co-repressor of
many nuclear receptors, RIP140, in the WAT of Fsp27
2/2 mice.
Therefore, the attainment of BAT–like property in the WAT of
Fsp27
2/2 mice is likely to be a combinatory effect of activation of
pathways promoting the conversion and downregulation of
pathways that inhibit the conversion of BAT to WAT. Fsp27
appears to act somewhere upstream to control signaling networks
such as cAMP pathway, Rb, p107 and RIP140 expression and
insulin signaling that maintains WAT identity (Fig. 6G). The
phenotype in Fsp27
2/2 WAT is reminiscent of that of FoxC2
overexpression transgenic mice [22] and p107 and Rb knockout
mice [23], where PGC1a and Ucp1 are upregulated and that
WAT of these genetically modified mice all showed brown
adipocyte-like metabolic activity. However, these Fsp27
2/2 WAT
may not fully function as a brown adipocyte as the relative levels of
Ucp1 is only approximately 5–10% of that of wild type BAT (data
not shown). The level of PGC1a and Cidea in Fsp27
2/2 WAT
were also not as high as in wild type BAT. Similarly,
mitochondrial cristea of Fsp27
2/2 white adipocytes were not as
tightly packed and regularly arranged as that of BAT.
Remarkably, the BAT-like phenotype in the WAT of Fsp27
2/2
mice can be mostly reproduced in MEFs differentiated in vitro. Our
observations suggest that the acquirement of BAT-like property in
WAT may require two steps, the first of which is T3-independent
and cell autonomous, and the subsequent step is T3-dependent. In
the first step, the changes mainly include smaller lipid droplets,
increased lipolysis, and reduced TAG storage in the basic
differentiation medium that contains pioglitazone and insulin. In
the second step, which requires T3 in the differentiation medium,
fatty acid b-oxidation was increased, accompanied by the
increased protein levels of brown fat specific genes (PGC1a,
Cidea, Ucp1) and mitochondrial proteins such as Cox IV. In this
study, we have also revealed the importance of T3 in increasing
mitochondrial activity and altering transcriptional program in the
WAT of Fsp27
2/2 mice. Fsp27 could functionally antagonize the
T3 action, which is a pleiotropic hormone regulating the
expression of many genes involved in adipocyte differentiation,
lipogenesis and lipolysis, and controls the induction and
maintenance of the WAT identity in vivo. Based on these data,
the phenotype of reduced lipid droplet size, increased lipolysis and
reduced TAG storage appears to be the primary defects in the
WAT of Fsp27
2/2 mice, while increased mitochondrial activation
and up-regulation of BAT specific markers are secondary effects.
The mechanism by which Fsp27 controls lipid droplet function
and mitochondrial activity is not clear. As certain portion of
endogenous Fsp27 proteins are localized to the lipid droplet
[31,32] (Fig. 1D), it may function to control lipid droplet
formation or inhibit lipolysis. Increased mitochondrial oxidative
activity and Ucp1 expression in the WAT of Fsp27
2/2 mice may
be a result of increased release of fatty acids to the cytosolic
fraction. Attainment of a BAT-like cell type with increased
mitochondrial activity in Fsp27
2/2 white adipocytes may reflect a
feedback control in regulating TG storage, resulting from a defect
in lipid droplet formation, lower TG storage and a lean
phenotype. Although Fsp27
2/2 and Perilipin (Plin)
2/2 mice have
a similar lean phenotype, the molecular mechanism by which
Fsp27 and Perilipin control energy storage and lipid droplet
formation appears to be different [31,33,34]. Plin
2/2 mice had
a defect in lipid storage due to increase lipolysis. As a result, lipids
were channelled into the circulation and other tissues. No increase
in mitochondrial activity and upregulation of mitochondrial gene
expression was observed in Plin
2/2 mice. Fsp27, on the other
hand, appears to control lipid storage and insulin sensitivity by
regulating the expression levels of FoxC2, Rb/p107, RIP140,
PPAR, PGC1, AKT2, GluT4 and mitochondrial proteins in
addition to regulating lipid droplet size.
Paradoxically, we observed larger lipid droplets, slightly reduced
mitochondrial protein expression and mitochondrial activity,
irregular structure of mitochondrial cristae and reduced levels of
mitochondrial proteins in Fsp27
2/2 brown adipocytes. All these
changes are somewhat opposite to the changes observed in the
Fsp27
2/2 WAT and are apparently associated with BAT
dysfunction. The precise role of Fsp27 in regulating BAT function
is not clear. The reduced activity in the BAT of Fsp27
2/2 mice
may be related to a decrease of sympathetic innervation and
activity surrounding the BAT. Further analysis will be needed to
address Fsp27’s molecular role in BAT. Furthermore, increased
WAT activity coupled with reduced BAT activity was also
observed in several genetically modified lean mouse models such
as transgenic mice over-expressing A-ZIP, a nuclear form of
SREBP1, Ucp1 and FoxC2 in WAT [22,35–37] as well as
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activity could in turn inhibit BAT activity.
We observed that Fsp27
2/2 mice had slightly increased body
temperatures under both feeding and fasting conditions in
particular for female mice under high fat diet condition, indicating
a possible increase in thermogenic activity. We found that the
body temperature within the first hour of cold exposure was
similar between wild type and Fsp27
2/2 mice. Intriguingly, the
body temperature in Fsp27
2/2 mice became lower than the wild
type mice at one hour of cold exposure and decreased even further
thereafter. Therefore, Fsp27
2/2 mice appear to have slightly
increased thermogenic activity in ambient condition, but they
become hypothermic with prolonged cold exposure. The slight
increase in thermogenic activity in ambient temperature in
Fsp27
2/2 mice may be due to increased Ucp1 expression and
enhanced mitochondrial activity in their WAT. However, we have
evaluated Ucp1 protein levels in WAT of Fsp27
2/2 mice and
observed that the amount of Ucp1 in Fsp27
2/2 WAT is
approximately only 5% of that in wild type BAT (data not
shown). Furthermore, mitochondrial cristea structure of Fsp27
2/2
white adipocytes was not arranged as regularly as wild type brown
adipocytes. In addition, significantly lower amount of TG was
stored in Fsp27
2/2 white adipocytes, resulting in limited fuel for
WAT to produce heat when exposed to cold. Therefore, although
the white adipocytes of Fsp27
2/2 mice had increased Ucp1
expression, their capacity in generating heat and to increase body
temperature when animals were exposed to cold with prolonged
time remains unclear. Importantly, maintenance of body temper-
ature under prolonged cold treatment would require coordination
between BAT (non-shivering) and muscle (shivering). As Fsp27
2/2
mice are leaner and had a problem storing lipid, hence
hypothermia seen in Fsp27
2/2 mice may be due to the reduced
lipid storage, which translates into lesser fuel for muscle activity.
We speculate that the BAT-like property in the WAT of Fsp27
2/2
mice could contributes to the increased energy expenditure and
lean phenotype, but could not serve to maintain body temperature
when animals are exposed to prolong cold treatment. Taken
together, our study has clearly demonstrated that Fsp27 acts as a
novel regulator to control gene expression of crucial metabolic
regulators, mitochondrial activity and white adipocyte identity.
Therefore, Fsp27 could serve as a potential therapeutic target for
the control of obesity and diabetes.
Materials and Methods
Generation of Fsp27 knockout mice
Procedures for the isolation of Fsp27 genomic clones, generation
of Fsp27-deficient mice, and routine maintenance of mouse strain
were essentially the same as previously described [6]. Animals
were fed with either normal chow diet (5053, PicoLab Rodent Diet
20) or high-fat diet (D12331, 58% of kilocalories from fat;
Research Diet). Mice experiments were carried out in the In Vivo
Modeling Unit, Institute of Molecular and Cell Biology and
animal facility in Department of Biological Sciences and
Biotechnology, Tsinghua University. Mice handling procedures
were in accordance with the Responsible Care and Use of
Laboratory Animals (RCULA) guideline set by the National
University of Singapore and Tsinghua University.
Genotyping, RNA extraction, semi-quantitative real-time
PCR
Genomic DNA was isolated from mouse tails as previously
described [39]. Total RNA was isolated using the TRIzol reagent
(Invitrogen, USA). The first-strand cDNAs were synthesized from
1 mg of total RNA with oligo-(dT) 20 primers using Superscript III
RT kit (Invitrogen, USA) according to the manufacturer’s
protocol. Real-time PCRs were performed with ABI SYBR
GREEN PCR Master Mix in the MX3000P real-time PCR
system (Stratagene, USA) according to the manufacturer’s
instruction. Results were normalized to b-actin level in each
sample. Primer sequences for genotype and real-time PCR
analyses are available upon request.
Adiposity index, electron microscopy, histological
analysis, whole body O2 consumption, food intake
measurement and core body temperature
Procedures for adiposity index analysis, electron microscopy,
H&E staining and whole body O2 consumption were essentially
the same as described by Li et al [26]. For histological analysis,
WAT was fixed, dehydrated, embedded and transversely sectioned
into 5 mm piece for further staining. For whole body O2
consumption assessment, mice were adapted for 8 hours in the
metabolic chamber before reading were taken periodically at
15 min intervals for the next 10 h. Mice were given free access to
food and water during measurement. For food intake measure-
ment, two or three mice were house in a cage. The amount of
normal diet consumed was carefully monitored at 10:00 a.m. local
time very morning for a period of one month. Measurement of
core body temperature of the mice is essentially the same as
describe by Zhuo et al [6]
Glucose and insulin tolerance tests (GTT and ITT)
We carried out glucose and insulin tolerance tests (GTT and
ITT) by intraperitoneal injection of glucose (1.0 g per kg of body
weight) and recombinant human insulin (0.5 unit per kg body
weight) into fasting mice (16 hour or 4 hour for GTT and ITT,
respectively). We took tail blood samples before (0 min) and 15,
30, 60, 90, and 120 min after injection, to measure glucose levels.
Glucose levels were measured by a blood glucose meter (Roche).
Blood chemistry
NEFA, TG, HDL, LDL and Cholesterol were quantified using
NEFA-C, L-Type Triglyceride H, HDL-Cholesterol E, L-Type
LDL-C and Cholesterol E kits according to manufacturer’s
instructions (Wako Pure Chem, Japan). Insulin levels (CRYSTAL
CHEM., USA) were measured according to manufacturer’s
instruction.
Mitochondria O2 consumption from tissue
Mitochondria were isolated essentially as described [40].
Isolated mitochondria was resuspended in MRB buffer (120 mM
KCl, 20 mM sucrose, 3 mM HPEPS-KOH, pH 7.2, 3 mM
KH2PO4, 2 mM MgCl2 and 2 mM EGTA) containing 0.5%
(w/v) BSA. 200 mg of mitochondrial protein was added to a
chamber equipped with a Clark-type O2 electrode (Hansatech,
USA) that contained 1 ml of MRB buffer maintained at 37uC.
Mitochondrial activity measurement was initiated by the addition
of 5 mM succinate and 1 mM ADP. Rate of oxygen consumption
was monitored for 5-8 minutes before termination of experiment
with 1mM KCN.
Cytochrome oxidase activity
Cytochrome oxidase activity (Cox) activity was measured as
described [21] with the following modifications. Reduced
cytochrome c was prepared by incubating 5 mM DTT with
21.8 mM cytochrome C on ice for 15 min. To test Cox activity,
tissue was homogenized in Buffer C (30 mM potassium phosphate,
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centrifuged at 600g for 2 minutes to remove tissue clumps and fat
cake. 50 mg of total protein from the infranatant was added to
Buffer C containing 0.01 mmol of reduced cytochrome C and
measured immediately with a spectrophotometer. Cytochrome
oxidase activity was monitored as the change of OD 550/565 ratio
per unit time.
Lipid extraction and TLC assay
Total lipid was isolated from mouse tissue or cells as previously
described [41]. Dried lipids were reconstituted in chloroform/
methanol 2:1 and loaded onto a TLC plate (Sigma, USA). Lipids
were resolved in hexane/diethyl ether/acetic acid 70:30:1 v/v.
TLC plates were sprayed with 10% CuSO4 in 10% phosphoric
acid and developed by drying in a 150uC oven.
Western blot analysis
Tissue or cultured cells for western blot analysis of total lysate
were lysed in RIPA buffer (20 mM HEPES-KOH pH 7.5,
150 mM NaCl, 1 mM EDTA, 10% Glycerol, 0.5% sodium
deoxycholate, 1% NP40, 0.1% SDS and protease inhibitor) and
analysed as previously described [6]. Western blot analysis for
insulin stimulated phosphorylation of IRS1, AKT and GLUT4
was performed as described [26]. Fsp27 and Cidea was detected
using polyclonal antibody raised against mouse Fsp27 and mouse
Cidea by injecting His-Tagged truncated Fsp27 (aa 1–190) and
Cidea (aa 1–195) into rabbit respectively as previously described
[42]. Antibodies against anti-tubulin (Sigma), anti-rat FABP
(Alpha Diagnostic.), anti-cytochrome c (Pharmingen), anti-CoxIV
(Molecular Probes), anti-Cpt1 (Alpha Diag.), anti-Cpt2 (Alpha
Diag.), anti-UCP3 (Research Diag. Inc.), Hsp60 (Chemicon), anti-
Pgc1a (Chemicon), Ucp1 (Research Diag. Inc.), PGC1a (Chemi-
con), IRS-1 (Upstate), phosphotyrosine (Upstate), Akt (Cell
Signaling), Phospho-Akt (Cell Sigaling), PPARa (Abcam), PPARd
(Abcam), PPARc (Research Diag. Inc.) and b-tublin (Sigma) were
used for western blot analysis.
Immunofluoresence assay
Immunofluorescence study was carried out on cells grown on
cover-slips. Cells were fixed in 3% paraformaldehyde/PBS
solution for 30 min at room temperature, followed by permeabi-
lization with 0.1% saponin/PBS for 15 mins. The cells were then
incubated with purified Fsp27 antibody and perilipin antibody
(Research Diag. Inc.). In MEF cells, intracellular lipids were
visualize with 20 mg/ml Bodipy 493/503. Fluoresencing cells were
visualize with Zeiss LSM510Meta cofocal and Zeiss Axiovert
200M microscope.
Cell culture
3T3-L1 cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen, USA) containing 10% fetal bovine
serum (FBS, Invitrogen, USA). Differentiation of 3T3-L1 cells
were initiated at 2 days post-confluent cells by the addition of
5 mg/ml of insulin, 1 mM dexamethasone (DEX), and 0.5 mM
isobutylmethylxanthine (IBMX) for 2 days and subsequently
replaced by DMEM/FBS supplemented only with 5 mg/ml
insulin for a further 2 days before replacing it with normal culture
medium. Mouse embryonic fibroblasts (MEF) were isolated from
13.5 day wild-type and Fsp27 mutant mouse embryos as described
[43]. Passage 2 of MEF was used for differentiation. For the
induction of MEF to differentiate into adipocytes, MEF cells were
grown for 2 days post confluence, and then differentiated in
DMEM/FBS supplemented with 8 mg/ml D-Pantothenic acid,
8 mg/ml Biotin, 1 mM DEX , 0.5 mM IBMX, 5 mg/ml insulin
and 1.0 mM pioglitazone (TAYANG Pharmaceutical Industry Co.
LTD, China), with or without 0.5 mM3 ,5 ,3 9-tri-iodothyronine
(T3). Two days later, the medium was changed to DMEM /FBS,
8 mg/ml D-Pantothenic acid, 8 mg/ml Biotin, 5 mg/ml insulin,
1 mM pioglitazone, with or without 0.5 mM T3. Cells were
collected after 8 days of differentiation and used for further
experiments.
Fatty acid b-oxidation
The procedure for measurement of fatty acid oxidation in MEF
was essentially the same as described [44]. MEF cells were seeded
in 12-well plates. After 8 days of differentiation, the cells were
washed three times with HBSS (Hanks’ balanced salt solution with
calcium and magnesium, 10 mM HEPES) buffer and prelabeled
with [9, 10(n)-
3H] palmitatic acid (1.0 mCi/well) with 22 mM
unlabeled palmitic acid and 0.5 mg/ml fatty acid-free BSA in
HBSS. After incubation at 37uC for 2 h, cells were washed with
HBSS three times and incubated in 0.5 ml HBSS buffer. At each
time point, the reaction medium was transferred to glass tube and
the cells were then washed 3 times with 0.5 ml HBSS which was
collected in the same tube. The resultant medium was extracted
with 8 ml Chloroform/Methanol (2:1), and the aqueous phase was
collected and used for radioactivity measurement in a liquid
scintillation counter.
Lipolysis assay in WAT and MEF cells
WAT isolated from three month old mice were cut into small
pieces and 8 days post differentiated MEF were used for lipolysis
assay [45]. Tissue pieces or cells were incubated in DMEM
(without phenol red) containing 1% fatty acid free BSA with or
without 1 mM isoproterenol as indicated. 100 ml of medium was
withdrawn at the indicated time points and used for the assay.
Glycerol level was determined using Free Glycerol determination
kit according to the manufacturer’s instruction (Sigma, USA).
Statistical analysis
All statistical analyses were calculated using Graphpad Prism
v4.0. Data consolidated were expressed as mean6sem and p value
was calculated using non-parametric student t-test.
Supporting Information
Figure S1 Generation of Fsp27 knockout mice. A. Fsp27 partial
genomic structure, gene targeting construct, and expected
homologous recombinant allele. Transcriptional disruption is
achieved with a copy of the Neo gene being inserted in place of
exon 2 and part of exon 3 in the opposite direction to
transcriptional orientation. B. Total triacylglycerol content
(TAG) in skeletal muscle (SM) and liver of 3 months old wildtype
(+/+) and Fsp272/2 (2/2) mice (n=3). C. Lipolysis rate of
WAT from wildtype (+/+) and Fsp272/2 (2/2) mice treated
with (Iso) or without (Basal) 1uM isoproterenol (n=4) for the
indicated time.
Found at: doi:10.1371/journal.pone.0002890.s001 (0.77 MB TIF)
Figure S2 Body temperature of animals under ambient
conditions. Retal temperature was taken from 6 months old
wildtype (+/+) and Fsp272/2 (2/2) mice fed ad libitum with
normal diet (ND) or high fat diet (HFD) or fasted for 18 hours
(ND: Male: +/+: n=16, 2/2: n=17; Female: +/+: n=16, 2/2:
n=16. HFD: Male: +/+: n=18, 2/2: n=19; Female: +/+:
n=15, 2/2: n=22.).
Found at: doi:10.1371/journal.pone.0002890.s002 (0.59 MB TIF)
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western blot analysis performed for, A. IRS1 or phosphor-IRS1
(pIRS1), B. AKT2 or phosphor-AKT2 (pAKT2) and C. GLUT4
in WAT of 3 months old wildtype (WT), Fsp272/2, leptin
deficient (ob/ob) and leptin/Fsp27 double deficient (ob/ob/
Fsp272/2) mice (n=3).
Found at: doi:10.1371/journal.pone.0002890.s003 (0.32 MB TIF)
Figure S4 No difference of levels of AKT and phosphor-AKT in
Fsp272/2and ob/ob/Fsp272/2 mice. 3 months old mice that
were fasted for 4 hours were intraperitoneally injected with 40mg/
kg body weight of insulin. AKT proteins were immunoprecipitated
with antibody against AKT and subsequently immunoblotted with
antibodies again AKT or phosphor-AKT (pAKT). A, C& E.
Western blot analysis for levels of total AKT and pAKT stimulated
with and without insulin in BAT, skeleton muscle (SM) and liver of
wild type (WT) and Fsp27 mutant (Fsp272/2) mice. B, D& F.
Western blot analysis for levels of total AKT and insulin stimulated
pAKT in BAT, skeletal muscle (SM) and liver of ob/ob and ob/
ob/Fsp272/2 mice. Actin was used as the loading control.
Found at: doi:10.1371/journal.pone.0002890.s004 (1.80 MB TIF)
Figure S5 Western Blot analysis of total BAT tissue lysate from
wildtype (Fsp27+/+) or Fsp27 null (Fsp272/2) mice. b-tubulin
was used as the loading control. Each panel is a representative of 4
individual experiments. Tubb represents tubulin.
Found at: doi:10.1371/journal.pone.0002890.s005 (1.03 MB TIF)
Figure S6 Densitometric reading of relative protein level in
western blot analysis performed for the indicated protein of
wildtype (Fsp27+/+) or Fsp27 null (Fsp272/2) mice in Day 8
post-differentiated MEF cells with (+T3) or without (2T3)
triiodothyronine (n=3).
Found at: doi:10.1371/journal.pone.0002890.s006 (0.44 MB TIF)
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